A trustee in the Delaware bankruptcy of Imerys Talc America Inc. has appointed 11 plaintiffs attorneys to represent cancer victims with claims against the talc supplier.

Imerys, the primary talc supplier to Johnson & Johnson, filed for Chapter 11 bankruptcy petition Feb. 13, citing “significant potential liabilities” associated with lawsuits linking talcum powder to cancer. The U.S. division of Paris-based Imerys, with headquarters in San Jose, California, plans to set up a litigation trust to manage talcum powder claims, while continuing to operate business as usual.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]